India’s Pharma Sector at Centre of Global Growth As It Aims To Reach USD 130 Billion

New Delhi: India’s pharmaceutical sector has seen remarkable growth in past few years and is expected to reach a market value of USD 65 billion by end of 2024 and double to USD 130 billion by 2030. As third-largest producer of pharmaceuticals globally, India is a key player in global healthcare supply chain, earning its reputation as “Pharmacy of World.” To showcase latest vancements in pharmaceutical industry, 17th edition of CPHI & PMEC India tre show is set to take place from November 26th to 28th at India Expo Centre in Greater Noida.

event will serve as a comprehensive marketplace for pharmaceutical executives, buyers, hospital ministrators, and government officials to explore cutting-edge solutions for drug manufacturing, distribution, and technology. Over three days, CPHI & PMEC India will provide attendees with opportunity to engage in strategic networking, learn from industry experts, and discover innovative products that are shaping future of industry.

event, which is being organized by Informa Markets in India, will showcase latest vancements in pharmaceutical industry, including machinery, technology, and ingredients, while focusing on sustainability and innovation. It also exemplifies growth by connecting over 2,000 exhibitors and attracting global participation from countries like USA, UAE, Japan, South Korea, Vietnam, and UK.

This year’s expo will feature Pharma Connect Congress, a two-day garing focused on critical industry topics such as continuous innovation, agile manufacturing, biosimilars, and digital transformation. se discussions are designed to dress some of key challenges facing sector, including option of new technologies and complexities of biosimilar manufacturing. ditionally, Pharma Leers Roundtable will bring toger senior industry executives to discuss strategic pathways for dressing unmet clinical needs and driving future innovation.

Yogesh Mudras, Managing Director of Informa Markets in India, remarked, “India’s pharma industry has grown exponentially, with a CAGR of 9.43% over last nine years. CPHI & PMEC India plays a pivotal role in showcasing this growth, connecting industry leers, and offering real-time insights into future of pharma.”

As India’s premier pharmaceutical event, CPHI & PMEC India 2024 promises to be a landmark occasion, highlighting India’s growing influence in global pharmaceutical landscape.